MJ

Markku Jalkanen

CEO

Faron

Turku


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Faron
Industry
pharmaceuticals
Employees
49.0
Seniority
C suite
Annual Revenue
857000.0

Technologies

MailJet Sendgrid Outlook Drupal Mobile Friendly YouTube WordPress.org Google Analytics Google Tag Manager Nginx

Keywords

drug discovery drug development pharmaceuticals novel treatments for medical conditions with significant unmet needs ards acute respiratory distress syndrome cancer immunotherapy biopharmaceutical pharmaceutical manufacturing immunotherapy cancer treatment clinical trials phase i/ii bexmarilimab anti-clever-1 antibody hematological cancers solid tumors macrophage-targeting precision medicine treatment resistance oncology research patient outcomes research & development therapy combinations novel therapies drug candidates scientific advisory board bioinformatics market analysis financial reports investment strategy risk management clinical efficacy immune system patient-centered care biotech investment healthcare innovation pharmaceutical pipeline biotech research neoplasms novel combination therapies drug efficacy patient engagement sustainability in healthcare clinical development cancer research financial analysis peer-reviewed studies drug commercialization healthcare investment biopharma immuno-oncology market growth 9% r&d expenses aim listing investor relations medical health care health wellness & fitness hospital & health care information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans